Clinical Trials on Fluorodeoxyglucose F18 in Germany
Total 5 results
-
Provitro GmbHCharite University, Berlin, Germany; AstraZenecaCompletedMutations in Exons 18 to 21Germany
-
Vivasure Medical LimitedCompleted18 to 24 F Percutaneous Femoral Arteriotomy ClosureGermany
-
University Hospital TuebingenUnknownPatients Above 18 YearsGermany
-
University Medicine GreifswaldCompletedHealthy Middle-aged Subjects | Age Range Was 18 to 31 Years | Caucasian Whites | Males and FemalesGermany
-
Bristol-Myers SquibbCompletedDermatomyositis | Polymyositis | Autoimmune Necrotizing Myopathy | Overlap Myositis | Juvenile Myositis Above the Age of 18France, United States, Australia, Brazil, Czechia, Germany, Italy, Japan, Korea, Republic of, Mexico, Sweden